Intra-operative Pyloric BOTOX Injection Versus Pyloric Surgery for Prevention of Delayed Gastric Emptying After Esophagectomy

Overview

Journal Surg Endosc

Publisher Springer

Specialties Gastroenterology
General Surgery
Radiology

Date 2024 Aug 12

PMID 39134721

Authors

Samir H Saeed

Andrew J Sinnamon

Jacques P Fontaine

Rutika J Mehta

Luis R Pena

Shaffer R S Mok

Jobelle J R Baldonado

Jose M Pimiento

Affiliations

Soon will be listed here.

Abstract

Background: Delayed gastric emptying (DGE) is a common complication after esophagectomy. BOTOX injections and pyloric surgeries (PS), including pyloroplasty (PP) and pyloromyotomy (PM), are performed intraoperatively as prophylaxis against DGE. This study compares the effects of pyloric BOTOX injection and PS for preventing DGE post-esophagectomy.

Methods: We retrospectively reviewed Moffitt's IRB-approved database of 1364 esophagectomies, identifying 475 patients receiving BOTOX or PS during esophageal resection. PS was further divided into PP and PM. Demographics, clinical characteristics, and postoperative outcomes were compared using Chi-Square, Fisher's exact test, Wilcoxon rank-sum, and ANOVA. Propensity-score matching was performed between BOTOX and PP cohorts.

Results: 238 patients received BOTOX, 108 received PP, and 129 received PM. Most BOTOX patients underwent fully minimally invasive robotic Ivor-Lewis esophagectomy (81.1% vs 1.7%) while most PS patients underwent hybrid open/Robotic Ivor-Lewis esophagectomy (95.7% vs 13.0%). Anastomotic leak (p = 0.57) and pneumonia (p = 0.75) were comparable between groups. However, PS experienced lower DGE rates (15.9% vs 9.3%; p = 0.04) while BOTOX patients had less postoperative weight loss (9.7 vs 11.45 kg; p = 0.02). After separating PP from PM, leak (p = 0.72) and pneumonia (p = 0.07) rates remained similar. However, PP patients had the lowest DGE incidence (1.9% vs 15.7% vs 15.9%; p = < 0.001) and the highest bile reflux rates (2.8% vs 0% vs 0.4%; p = 0.04). Between matched cohorts of 91 patients, PP had lower DGE rates (18.7% vs 1.1%; p = < 0.001) and less weight loss (9.8 vs 11.4 kg; p = < 0.001). Other complications were comparable (all p > 0.05). BOTOX was consistently associated with shorter LOS compared to PS (all p = < 0.001).

Conclusion: PP demonstrates lower rates of DGE in unmatched and matched analyses. Compared to BOTOX, PS is linked to reduced DGE rates. While BOTOX is associated with more favorable LOS, this may be attributable to difference in operative approach. PP improves DGE rates after esophagectomy without improving other postoperative complications.

References

Uhlenhopp D, Then E, Sunkara T, Gaduputi V . Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol. 2020; 13(6):1010-1021. DOI: 10.1007/s12328-020-01237-x. View

Seesing M, Kingma B, Weijs T, Ruurda J, van Hillegersberg R . Reducing pulmonary complications after esophagectomy for cancer. J Thorac Dis. 2019; 11(Suppl 5):S794-S798. PMC: 6503282. DOI: 10.21037/jtd.2018.11.75. View

Tham J, Nixon M, Ariyarathenam A, Humphreys L, Berrisford R, Wheatley T . Intraoperative pyloric botulinum toxin injection during Ivor-Lewis gastroesophagectomy to prevent delayed gastric emptying. Dis Esophagus. 2018; 32(6). DOI: 10.1093/dote/doy112. View

Benedix F, Willems T, Kropf S, Schubert D, Stubs P, Wolff S . Risk factors for delayed gastric emptying after esophagectomy. Langenbecks Arch Surg. 2017; 402(3):547-554. DOI: 10.1007/s00423-017-1576-7. View

Konradsson M, van Berge Henegouwen M, Bruns C, Chaudry M, Cheong E, Cuesta M . Diagnostic criteria and symptom grading for delayed gastric conduit emptying after esophagectomy for cancer: international expert consensus based on a modified Delphi process. Dis Esophagus. 2019; 33(4). PMC: 7150655. DOI: 10.1093/dote/doz074. View

Low D, Alderson D, Cecconello I, Chang A, Darling G, DJourno X . International Consensus on Standardization of Data Collection for Complications Associated With Esophagectomy: Esophagectomy Complications Consensus Group (ECCG). Ann Surg. 2015; 262(2):286-94. DOI: 10.1097/SLA.0000000000001098. View

Frederick A, Lorenz W, Self S, Schammel C, Bolton W, Stephenson J . Delayed Gastric Emptying Post-Esophagectomy: A Single-Institution Experience. Innovations (Phila). 2020; 15(6):547-554. DOI: 10.1177/1556984520961079. View

Zhang R, Zhang L . Management of delayed gastric conduit emptying after esophagectomy. J Thorac Dis. 2019; 11(1):302-307. PMC: 6384344. DOI: 10.21037/jtd.2018.11.101. View

Bagheri R, Fattahi S, Haghi S, Aryana K, Aryanniya A, Akhlaghi S . Botulinum toxin for prevention of delayed gastric emptying after esophagectomy. Asian Cardiovasc Thorac Ann. 2014; 21(6):689-92. DOI: 10.1177/0218492312468438. View

10.

Antonoff M, Puri V, Meyers B, Baumgartner K, Bell J, Broderick S . Comparison of pyloric intervention strategies at the time of esophagectomy: is more better?. Ann Thorac Surg. 2014; 97(6):1950-7. PMC: 4140218. DOI: 10.1016/j.athoracsur.2014.02.046. View

11.

Loo J, Ng A, Chan K, Oo A . Outcomes of Intraoperative Pyloric Drainage on Delayed Gastric Emptying Following Esophagectomy: A Systematic Review and Meta-analysis. J Gastrointest Surg. 2023; 27(4):823-835. DOI: 10.1007/s11605-022-05573-w. View

12.

Fuchs H, Broderick R, Harnsberger C, Divo F, Coker A, Jacobsen G . Intraoperative Endoscopic Botox Injection During Total Esophagectomy Prevents the Need for Pyloromyotomy or Dilatation. J Laparoendosc Adv Surg Tech A. 2016; 26(6):433-8. DOI: 10.1089/lap.2015.0575. View

13.

Martin J, Federico J, McKelvey A, Kent M, Fabian T . Prevention of delayed gastric emptying after esophagectomy: a single center's experience with botulinum toxin. Ann Thorac Surg. 2009; 87(6):1708-13. DOI: 10.1016/j.athoracsur.2009.01.075. View

14.

Nguyen N, Dholakia C, Nguyen X, Reavis K . Outcomes of minimally invasive esophagectomy without pyloroplasty: analysis of 109 cases. Am Surg. 2010; 76(10):1135-8. View

15.

Fok M, Cheng S, Wong J . Pyloroplasty versus no drainage in gastric replacement of the esophagus. Am J Surg. 1991; 162(5):447-52. DOI: 10.1016/0002-9610(91)90258-f. View

16.

Harada K, Yoshida N, Baba Y, Nakamura K, Kosumi K, Ishimoto T . Pyloroplasty may reduce weight loss 1 year after esophagectomy. Dis Esophagus. 2018; 31(3). DOI: 10.1093/dote/dox127. View

17.

Palmes D, Weilinghoff M, Colombo-Benkmann M, Senninger N, Bruewer M . Effect of pyloric drainage procedures on gastric passage and bile reflux after esophagectomy with gastric conduit reconstruction. Langenbecks Arch Surg. 2007; 392(2):135-41. DOI: 10.1007/s00423-006-0119-4. View

18.

Nagpal K, Ahmed K, Vats A, Yakoub D, James D, Ashrafian H . Is minimally invasive surgery beneficial in the management of esophageal cancer? A meta-analysis. Surg Endosc. 2010; 24(7):1621-9. DOI: 10.1007/s00464-009-0822-7. View

19.

Mannell A, McKnight A, Esser J . Role of pyloroplasty in the retrosternal stomach: results of a prospective, randomized, controlled trial. Br J Surg. 1990; 77(1):57-9. DOI: 10.1002/bjs.1800770120. View